JP2010508030A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010508030A5 JP2010508030A5 JP2009534896A JP2009534896A JP2010508030A5 JP 2010508030 A5 JP2010508030 A5 JP 2010508030A5 JP 2009534896 A JP2009534896 A JP 2009534896A JP 2009534896 A JP2009534896 A JP 2009534896A JP 2010508030 A5 JP2010508030 A5 JP 2010508030A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- vaccine
- nucleic acid
- amino acid
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims 24
- 102000004169 proteins and genes Human genes 0.000 claims 24
- 229960005486 vaccine Drugs 0.000 claims 12
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 11
- 150000001413 amino acids Chemical class 0.000 claims 8
- 239000013598 vector Substances 0.000 claims 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 206010022000 influenza Diseases 0.000 claims 5
- 241000712461 unidentified influenza virus Species 0.000 claims 5
- 101710154606 Hemagglutinin Proteins 0.000 claims 4
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 4
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 4
- 101710176177 Protein A56 Proteins 0.000 claims 4
- 239000000185 hemagglutinin Substances 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 230000005764 inhibitory process Effects 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 230000003612 virological effect Effects 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 238000003556 assay Methods 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 244000144977 poultry Species 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 241000271566 Aves Species 0.000 claims 1
- 206010069767 H1N1 influenza Diseases 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 208000002979 Influenza in Birds Diseases 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 206010064097 avian influenza Diseases 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 201000010740 swine influenza Diseases 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86314206P | 2006-10-27 | 2006-10-27 | |
| US60/863,142 | 2006-10-27 | ||
| US11/923,326 US8202967B2 (en) | 2006-10-27 | 2007-10-24 | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| US11/923,326 | 2007-10-24 | ||
| PCT/US2007/082699 WO2008052173A2 (en) | 2006-10-27 | 2007-10-26 | Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013165132A Division JP2014012008A (ja) | 2006-10-27 | 2013-08-08 | 新規ｈ５タンパク質、それらをコードする核酸分子およびベクター、ならびにそれらの医薬的使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010508030A JP2010508030A (ja) | 2010-03-18 |
| JP2010508030A5 true JP2010508030A5 (https=) | 2010-12-16 |
| JP5442442B2 JP5442442B2 (ja) | 2014-03-12 |
Family
ID=39325469
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009534896A Active JP5442442B2 (ja) | 2006-10-27 | 2007-10-26 | 新規ｈ５タンパク質、それらをコードする核酸分子およびベクター、ならびにそれらの医薬的使用 |
| JP2013165132A Withdrawn JP2014012008A (ja) | 2006-10-27 | 2013-08-08 | 新規ｈ５タンパク質、それらをコードする核酸分子およびベクター、ならびにそれらの医薬的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013165132A Withdrawn JP2014012008A (ja) | 2006-10-27 | 2013-08-08 | 新規ｈ５タンパク質、それらをコードする核酸分子およびベクター、ならびにそれらの医薬的使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8202967B2 (https=) |
| EP (1) | EP2086576B8 (https=) |
| JP (2) | JP5442442B2 (https=) |
| KR (2) | KR101520307B1 (https=) |
| AU (1) | AU2007308869B2 (https=) |
| BR (1) | BRPI0718183B8 (https=) |
| CA (1) | CA2664914C (https=) |
| CO (1) | CO6210831A2 (https=) |
| DK (1) | DK2086576T3 (https=) |
| ES (1) | ES2391123T3 (https=) |
| MX (1) | MX2009004243A (https=) |
| MY (1) | MY150226A (https=) |
| PL (1) | PL2086576T3 (https=) |
| PT (1) | PT2086576E (https=) |
| RU (1) | RU2479589C2 (https=) |
| SG (1) | SG176419A1 (https=) |
| SI (1) | SI2086576T1 (https=) |
| WO (1) | WO2008052173A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080065680A (ko) * | 2005-10-28 | 2008-07-14 | 베링거잉겔하임베트메디카인코퍼레이티드 | 종 간의 인플루엔자 병원체의 전파를 치료/예방하기 위한백신의 용도 |
| US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| DK2134360T3 (en) | 2007-03-14 | 2016-02-22 | Takeda Vaccines Inc | Purification of virus-like particle |
| RU2559527C2 (ru) | 2008-11-28 | 2015-08-10 | Мериал Лимитед | Рекомбинантная вакцина от птичьего гриппа и её применение |
| US20110305748A1 (en) * | 2010-03-11 | 2011-12-15 | Immune Design, Corp. | Vaccines for Pandemic Influenza |
| BR112013007946B1 (pt) | 2010-10-04 | 2022-07-12 | Massachusetts Institute Of Technology | Composições farmacêuticas e imunogênicas compreendendo polipeptídeos de hemaglutinina |
| AR088028A1 (es) * | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| WO2014127825A1 (en) * | 2013-02-21 | 2014-08-28 | Boehringer Ingelheim Vetmedica Gmbh | H5 proteins of h5n1 influenza virus for use as a medicament |
| JP2015015931A (ja) * | 2013-07-12 | 2015-01-29 | 株式会社Ｕｍｎファーマ | ウイルス様粒子を含む培養物の製造方法 |
| JOP20190088A1 (ar) | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
| WO2020093984A1 (en) * | 2018-11-06 | 2020-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic composition against avian influenza virus h5 subtype |
| CN117229370B (zh) * | 2022-06-08 | 2024-11-01 | 中科南京生命健康高等研究院 | H5n6禽流感广谱性疫苗的开发及其应用 |
| WO2026013161A1 (en) | 2024-07-10 | 2026-01-15 | Boehringer Ingelheim Vetmedica Gmbh | Prime and boost vaccination for the treatment and prevention of avian influenza infections in avians |
| WO2026013162A1 (en) | 2024-07-10 | 2026-01-15 | Boehringer Ingelheim Vetmedica Gmbh | Herpes virus of turkey vector based h5ha vaccine for the treatment and prevention of avian influenza infections in turkeys |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US382425A (en) | 1888-05-08 | Brandt | ||
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US4769331A (en) | 1981-09-16 | 1988-09-06 | University Patents, Inc. | Recombinant methods and materials |
| US5364773A (en) | 1991-03-07 | 1994-11-15 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| US5833975A (en) | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| US4552758A (en) | 1983-12-20 | 1985-11-12 | St. Jude Children's Research Hospital | Human use of avian-human reassortants as vaccines for influenza A virus |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| IE872748L (en) | 1986-10-16 | 1988-04-16 | Arjomari Europ | Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5811128A (en) | 1986-10-24 | 1998-09-22 | Southern Research Institute | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| WO1990001543A1 (fr) | 1988-07-29 | 1990-02-22 | Intracel Corporation | Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo |
| CA2003300A1 (en) | 1988-11-21 | 1990-05-21 | Franklin Volvovitz | Skin test and test kit for aids |
| ES2116269T3 (es) | 1989-03-21 | 1998-07-16 | Vical Inc | Expresion de secuencias exogenas de polinucleotidos en un vertebrado. |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5591439A (en) | 1989-03-24 | 1997-01-07 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
| US5552143A (en) | 1989-03-24 | 1996-09-03 | The Wistar Institute Of Anatomy & Biology | Recombinant cytomegalovirus vaccine |
| US5690938A (en) | 1989-07-07 | 1997-11-25 | Oravax, Inc. | Oral immunization with multiple particulate antigen delivery system |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| GB9001766D0 (en) | 1990-01-25 | 1990-03-28 | Univ Court Of The University O | Vaccines |
| US5643577A (en) | 1990-04-24 | 1997-07-01 | The University Of Newcastle Research Associates Limited | Oral vaccine comprising antigen surface-associated with red blood cells |
| US5997878A (en) | 1991-03-07 | 1999-12-07 | Connaught Laboratories | Recombinant poxvirus-cytomegalovirus, compositions and uses |
| DE69233158T2 (de) | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
| ATE181108T1 (de) | 1991-08-26 | 1999-06-15 | Immuno Ag | Direkt molekuläre klonierung eines modifizierten genoms eines chordopocken-virus |
| US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| US5807722A (en) | 1992-10-30 | 1998-09-15 | Bioengineering Resources, Inc. | Biological production of acetic acid from waste gases with Clostridium ljungdahlii |
| US5846945A (en) | 1993-02-16 | 1998-12-08 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
| EP0620277A1 (en) | 1993-03-18 | 1994-10-19 | Merck & Co. Inc. | Nucleic acid pharmaceuticals |
| FR2711670B1 (fr) | 1993-10-22 | 1996-01-12 | Pasteur Institut | Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite. |
| ATE475668T1 (de) | 1994-01-27 | 2010-08-15 | Univ Massachusetts Medical | Immunisierung durch impfung von dns transkriptionseinheit |
| AU694519B2 (en) | 1994-04-29 | 1998-07-23 | Immuno Aktiengesellschaft | Recombinant poxviruses with foreign polynucleotides in essential regions |
| AU711702B2 (en) | 1995-03-23 | 1999-10-21 | Cambridge University Technical Services Limited | Vectors for gene delivery |
| EP0979101B1 (en) | 1996-07-03 | 2010-10-27 | Merial, Inc. | Recombinant canine adenovirus 2 (cav2) containing exogenous dna |
| US6183752B1 (en) | 1997-02-05 | 2001-02-06 | Pasteur Merieux Serums Et Vaccins | Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
| US6204281B1 (en) | 1998-07-10 | 2001-03-20 | Novartis Ag | Method of treatment and pharmaceutical composition |
| MXPA02010642A (es) | 2000-04-28 | 2004-05-17 | St Jude Children S Res Hospital | Sistema de transfeccion de adn para la generacion de virus de influenza infeccioso. |
| US20020095197A1 (en) | 2000-07-11 | 2002-07-18 | Lardo Albert C. | Application of photochemotherapy for the treatment of cardiac arrhythmias |
| WO2002062381A1 (en) | 2001-02-05 | 2002-08-15 | Hisamitsu Pharmaceutical Co., Inc. | Baculovirus vector vaccine |
| US20040219208A1 (en) | 2001-08-03 | 2004-11-04 | Ryu Kawamura | Sustained-release medicines |
| DE60326369D1 (de) | 2002-08-27 | 2009-04-09 | Dow Agrosciences Llc | Verwendung von hitzelabilem escherichia-coli-toxin als adjuvans bei geflügel |
| US7566458B2 (en) | 2003-06-16 | 2009-07-28 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| CN1816903B (zh) | 2003-07-04 | 2011-10-05 | Nxp股份有限公司 | 前体溶液及其制备和使用方法 |
| WO2005107797A1 (en) | 2004-03-09 | 2005-11-17 | Chiron Corporation | Influenza virus vaccines |
| CA2879182C (en) | 2004-05-25 | 2017-02-14 | Medimmune, Inc. | Influenza hemagglutinin and neuraminidase variants |
| CN1748795A (zh) * | 2004-09-17 | 2006-03-22 | 金宁一 | 多价禽流感重组活载体疫苗 |
| RU2283139C1 (ru) * | 2005-03-21 | 2006-09-10 | Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации | Способ получения антигенов для вакцины против вирусов гриппа |
| KR20080052509A (ko) * | 2005-04-11 | 2008-06-11 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션 | 유행성 독감 바이러스에 대한 백신 |
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| JP5714799B2 (ja) | 2005-10-18 | 2015-05-07 | ノババックス インコーポレイテッド | 機能的インフルエンザウイルス様粒子（ｖｌｐ） |
| KR20080065680A (ko) * | 2005-10-28 | 2008-07-14 | 베링거잉겔하임베트메디카인코퍼레이티드 | 종 간의 인플루엔자 병원체의 전파를 치료/예방하기 위한백신의 용도 |
| US20100150941A1 (en) | 2006-09-13 | 2010-06-17 | Dso National Laboratories | Hemagglutinin antibody and uses thereof |
| US8202967B2 (en) * | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| US9555093B2 (en) | 2010-04-30 | 2017-01-31 | Temasek Life Sciences Laboratory Limited | Universal vaccine against H5N1 lineages |
| AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
| WO2014127825A1 (en) | 2013-02-21 | 2014-08-28 | Boehringer Ingelheim Vetmedica Gmbh | H5 proteins of h5n1 influenza virus for use as a medicament |
-
2007
- 2007-10-24 US US11/923,326 patent/US8202967B2/en active Active
- 2007-10-26 WO PCT/US2007/082699 patent/WO2008052173A2/en not_active Ceased
- 2007-10-26 CA CA2664914A patent/CA2664914C/en active Active
- 2007-10-26 ES ES07863555T patent/ES2391123T3/es active Active
- 2007-10-26 MY MYPI20091667A patent/MY150226A/en unknown
- 2007-10-26 EP EP07863555.4A patent/EP2086576B8/en active Active
- 2007-10-26 KR KR1020097010893A patent/KR101520307B1/ko active Active
- 2007-10-26 KR KR20157008683A patent/KR20150041200A/ko not_active Withdrawn
- 2007-10-26 DK DK07863555.4T patent/DK2086576T3/da active
- 2007-10-26 RU RU2009119597/10A patent/RU2479589C2/ru active
- 2007-10-26 JP JP2009534896A patent/JP5442442B2/ja active Active
- 2007-10-26 AU AU2007308869A patent/AU2007308869B2/en active Active
- 2007-10-26 PL PL07863555T patent/PL2086576T3/pl unknown
- 2007-10-26 SG SG2011077781A patent/SG176419A1/en unknown
- 2007-10-26 PT PT07863555T patent/PT2086576E/pt unknown
- 2007-10-26 BR BRPI0718183A patent/BRPI0718183B8/pt active IP Right Grant
- 2007-10-26 SI SI200731036T patent/SI2086576T1/sl unknown
- 2007-10-26 MX MX2009004243A patent/MX2009004243A/es active IP Right Grant
-
2009
- 2009-04-27 CO CO09042413A patent/CO6210831A2/es active IP Right Grant
-
2012
- 2012-05-21 US US13/476,405 patent/US8592558B2/en active Active
-
2013
- 2013-08-08 JP JP2013165132A patent/JP2014012008A/ja not_active Withdrawn
- 2013-10-23 US US14/061,249 patent/US9375469B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010508030A5 (https=) | ||
| RU2609645C2 (ru) | Экспрессионные системы | |
| RU2009119597A (ru) | Новые белки н5, кодирующие их молекулы нуклеиновых кислот и векторы, и их применение в медицине | |
| JP2014527526A5 (https=) | ||
| CN104780937A (zh) | 涉及由多核苷酸编码的免疫原性多肽的新型初免-加强方案 | |
| JP2011528222A5 (https=) | ||
| JP2010500399A5 (https=) | ||
| AR088028A1 (es) | Proteinas h5, de h5n1 para un uso medicinal | |
| WO2012092934A1 (en) | Monomeric and multimeric immunogenic peptides | |
| CA2380833A1 (en) | Proteins derived from white spot syndrome virus and uses thereof | |
| CN104619718A (zh) | 源自病毒蛋白的肽用作免疫原和配药成分 | |
| CN101186637A (zh) | 抑制流感病毒感染的方法及其药物 | |
| JP7403733B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JP2020509770A5 (https=) | ||
| CN111556896A (zh) | 交叉免疫抗原疫苗及其制备方法 | |
| CN101879312B (zh) | 广谱型流感疫苗及其制备方法 | |
| Li et al. | A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses | |
| ES2349153T3 (es) | Inhibidores del virus de la hepatitis c. | |
| EP2307036A1 (en) | Novel peptide adjuvant for influenza vaccination | |
| CN113069540B (zh) | 一种基于流感病毒载体的新型冠状病毒疫苗及其制备方法 | |
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| CN108348596A (zh) | 用牛免疫缺陷病毒Gag蛋白的重组病毒样颗粒 | |
| JPWO2002062381A1 (ja) | バキュロウイルスベクターワクチン | |
| JP2024545833A (ja) | コロナウイルス科ウイルスによる感染症の処置または予防のためのウイルス様粒子 | |
| CN116888139A (zh) | 诱导高水平i型干扰素的新型复制缺陷型甲型流感病毒 |